Abstract

The COVID-19 pandemic has presented unprecedented challenges to global healthcare systems, economies, and societies. In response, there has been a surge in research efforts aimed at leveraging artificial intelligence (AI) and machine learning (ML) technologies to address various aspects of the pandemic. This paper explores the diverse applications of AI and ML in tackling COVID-19 challenges across different domains. In the realm of disease detection and diagnosis, AI and ML algorithms have been deployed to develop predictive models for early detection of COVID-19 cases based on clinical data, symptoms, and imaging scans. These models have the potential to enhance diagnostic accuracy, streamline triage processes, and facilitate timely interventions. Furthermore, AI-powered tools have been utilized for epidemiological modeling and forecasting to predict disease spread, assess the impact of interventions, and inform public health policies. By analyzing vast amounts of epidemiological data and incorporatingreal-time updates, these models contribute to evidence-based decision-making and resource allocation. In the domain of drug discovery and development, AI and ML techniques are revolutionizing the identification of potential therapeutic compounds, repurposing existing drugs, and accelerating the drug development pipeline. Virtual screening, molecular modeling, and drug-target interaction prediction are among the AI-driven approaches that hold promise for expediting the discovery of effective treatments for COVID-19. Moreover, AI-driven technologies play a crucial role in enhancing healthcare delivery and management during the pandemic. From remote patient monitoring and telemedicine solutions to AI-driven chat bots and virtual assistants, these technologies enable efficient triage, remote consultations, and personalized care delivery while minimizing exposure risks for healthcare workers and patients. Despite the remarkable progress, challenges remain in ensuring the ethical use of AI and ML technologies, addressing data privacy concerns, and mitigating algorithmic biases.